Nyse fsk

From December 2021 to December 2022, the

The price-to-earnings ratio for FS KKR Capital Corp. (NYSE: FSK) is 8.33x, which is above its average ratio. Moreover, the 36-month beta value for FSK is 1.41. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 0 as “overweight,” 7 as “hold,” and 0 as “sell.” The average price […]Investors Research Corp boosted its stake in shares of GSK plc (NYSE:GSK – Free Report) by 56.0% during the second quarter, according to the company in its most recent disclosure with the ...

Did you know?

PHILADELPHIA, June 9, 2021 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK) announced that it has priced an underwritten public offering of $400,000,000 in aggregate principal amount of its 2.625% ...Here’s what they said. FS KKR Capital Corp. (NYSE:FSK) Q4 2022 Earnings Call Transcript February 28, 2023 Operator: Good morning, ladies and gentlemen. Welcome to the FS KKR Capital Corp’s ...PHILADELPHIA and NEW YORK, Aug. 9, 2021 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), today reported net investment income of $116 million, or $0.77 per share for the second quarter ended June 30, 2021.The Company's net asset value ("NAV") was $26.84 per share as of June 30, 2021, compared to $26.03 per share as of …Post-merger, the combined FS KKR (NYSE:FSK) entity is now the second-largest BDC on the market ... FSK "sells" the new amended fee structure as a lower cost one for their shareholders. After all ...FS/KKR serves as the investment adviser to FS KKR Capital Corp. (NYSE: FSK), a publicly listed BDC. The Advisor manages over $15 billion in assets under management as of September 30, 2023. FS/KKR seeks to leverage its size, scale and market reach to invest primarily in upper middle market companies. FS/KKR and its affiliates have significant ...GSK (NYSE:GSK) has posted positive headline results from an interim analaysis of its DREAMM-7 head-to-head phase 3 trial for Blenrep (belantamab mafodotin) in treating relapsed or refractory ...FS KKR Capital Corp. (NYSE: FSK) Q1 2023 – Information as of March 31, 2023, unless otherwise noted An investment in FS KKR Capital Corp. (FSK) involves a high degree of risk and may be considered speculative. Investors are advised to consider the investment objectives, risks, and charges, and expenses of FSK carefully. Investors should readFS KKR Capital Corp. (NYSE: FSK), today announced its financial and operating results for the quarter and year ended December 31, 2022, and that its board of directors has declared a first quarter ...Sep 12, 2023 · FSK has a dividend yield of 7.06% which is higher than the Financial Services sector and the industry average. If we compare it with the Financial Services sector average of 3.52%, FS KKR Capital's dividend yield is 101% higher. Historically FSK's dividend yield has averaged at 22.8% in the last 5 years, which is more than the current one. One high-yielding dividend stock is FS KKR Capital Group (FSK 0.40%), which has a yield of 14.7%. Read on to see why FS KKR Capital's dividend is so high, as well as whether it's a good investment ...FS KKR Capital Stock (NYSE: FSK) stock price, news, charts, stock research, profile.FS KKR Capital Corp. (NYSE: FSK) today announced that it has completed its previously announced offering of $400 million in aggregate principal... FSK Prices Public Offering of $400 million 7.875% ...FS KKR Capital Corp (NYSE:FSK) is the 2 nd largest holding within BIZD with a portfolio weight of 12.95%, and it’s still one of the most undervalued BDCs I follow.(NYSE: FSK) Fs Kkr Capital's forecast annual revenue growth rate of -0.61% is forecast to beat the US Asset Management industry's average forecast revenue growth rate of -7.8%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.52%. Tranche Update on FS KKR Capital Corp. (NYSE : FSK)‘s Equity Buyback announced on June 16, 2021. May. 24: CI Wells Fargo Adjusts Price Target on FS KKR Capital to $18.50 From $17.75, Maintains Equal-Weight Rating May. 09: MTFSK Prices Public Offering of $500,000,000 3.250% Notes Due 2027. PHILADELPHIA, Jan. 10, 2022 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK) announced that it has priced an underwritten public offering of $500,000,000 in aggregate principal amount of its 3.250% un... Get a real-time FS KKR Capital Corp. (FSK) stock price quote with breaking ...Nov 13, 2023 · FS KKR Capital Corp (NYSE:FSK) is the 2 nd largest holding within BIZD with a portfolio weight of 12.95%, and it’s still one of the most undervalued BDCs I follow. Nov 24, 2020 · FSK will be the surviving entity and will continue to be managed by FS/KKR and trade on the New York Stock Exchange under the ticker symbol “FSK.” Michael Forman, Chairman and Chief Executive Officer of both FSK and FSKR, commented, “The merger of FSK and FSKR represents a significant step toward our long-term strategic goal of creating a ... GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple m yeloma. It has developed monoclonal antibodies to help treat different diseases.FS KKR Capital (NYSE:FSK) has a trailing price-to-earnings ratio of 8.30 and a forward price-to-earnings ratio of 6.41. What is FS KKR Capital's EPS forecast for next year? FS KKR Capital's earnings are expected to decrease from $3.12 per share to $3.04 per share in the next year, which is a -2.56% change. ...From the fund’s website, FSK is one of the largest BDCs and is a partnership between FS Investments and KKR Credit. FS/KKR serves as the investment adviser to FS KKR Capital Corp. [NYSE: FSK], a ...The innovative EV company is trying to get cars on the road as soon as safely possible. Fool.com contributor and finance professor Parkev Tatevosian discusses the steps that Fisker ( FSK -0.26% ...FS KKR Capital (NYSE:FSK) declares $0.70/share quarterly dividend.Forward yield 14.18%Payable on or about Jan. 3; for shareholders of record Dec.FS KKR Capital (NYSE:FSK) has a trailing price-to-earnings ratio of 8.30 and a forward price-to-earnings ratio of 6.41. What is FS KKR Capital's EPS forecast for next year? FS KKR Capital's earnings are expected to decrease from $3.12 per share to $3.04 per share in the next year, which is a -2.56% change. ...Jun 15, 2023 · This article compares portfolio creditPHILADELPHIA and NEW YORK , Oct. 10, 2023 /PRNewsw Dec 1, 2023 · The latest price target for . FS KKR Capital (NYSE: FSK) was reported by Oppenheimer on Wednesday, August 9, 2023.The analyst firm set a price target for 22.00 expecting FSK to rise to within 12 ... PHILADELPHIA and NEW YORK – June 16, 2021 – FS/KKR Advisor PHILADELPHIA and NEW YORK, Aug. 9, 2021 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), today reported net investment income of $116 million, or $0.77 per share for the second quarter ended June 30, 2021.The Company's net asset value ("NAV") was $26.84 per share as of June 30, 2021, compared to $26.03 per share as of …PHILADELPHIA, June 15, 2020 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), a leading publicly traded business development company focused on providing customized credit solutions to private middle market U.S. companies, reported that its previously announced reverse stock split became effective following the close of trading on June 15, … Stock analysis for FS KKR Capital Corp (FSK:New York) including s

PHILADELPHIA and NEW YORK, June 16, 2021 /PRNewswire/ -- FS/KKR Advisor, LLC (FS/KKR), a partnership between FS Investments and KKR Credit Advisors (US), today announced the completion of the merger between FS KKR Capital Corp. (NYSE: FSK) and FS KKR Capital Corp. II (NYSE: FSKR). The combined company will …GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly) in combination with carboplatin and paclitaxel, followed by Jemperli as a single agent for the treatment of adult patients with primary advanced or recurrent endometrial cancer that is mismatch repair …Both FS KKR ( NYSE: FSK) and Main Street Capital ( NYSE: MAIN) are high-yield business development companies (i.e., BDCs) with investment grade balance sheets. MAIN is internally managed and has ...4,593.79 +25.99(+0.57%) Dow 30 36,223.13 +272.24(+0.76%) Nasdaq 14,299.23 +73.01(+0.51%) Russell 2000 1,852.23 +43.21(+2.39%) Crude Oil 74.31 -1.65(-2.17%) Gold 2,089.00 +31.80(+1.55%)... FSK's end-of-year net income for next year is expected to come in at $841.179 million and revenue at $1.778 billion, up from $92 million and $1.64 billion the year prior. Revenue is expected to ...

View the latest FS KKR Capital Corp. (FSK) stock price, news, historical charts, analyst ratings and financial information from WSJ.WebPHILADELPHIA and NEW YORK , Feb. 27, 2023 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK), today announced its financial and operating results for the quarter and year ended December 31, 2022 , and that its board of directors has declared a first quarter 2023 distribution totaling $0.70 per share.…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Stock quote & chart. NYSE: FSK. $19.91. Dec 1, 2023 4:10 PM . Possible cause: The BDCs managed by FS/KKR are FS KKR Capital Corp. (NYSE: FSK) and FS KKR.

David Gyung. FS KKR Capital Corp (NYSE:FSK) demonstrated a robust financial performance in Q3 2023, marked by an increased net and adjusted net investment income (NII), indicating a consistent ...FS KKR Capital Corp. (NYSE: FSK) has experienced an increase in hedge fund sentiment lately. FSK was in 22 hedge funds' portfolios at the end of September. There were 16 hedge funds in our ...4 Wall Street analysts have issued 12-month target prices for FS KKR Capital's stock. Their FSK share price targets range from $19.00 to $22.00. On average, they expect the company's share price to reach $20.88 in the next year. This suggests a possible upside of 4.8% from the stock's current price.

Like Caterpillar, IBM (NYSE :IBM ), which has a dividend yield of 4.6%, reported excellent, better-than-expected Q3 results recently. Specifically, IBM’s top line rose 4.6% year-over-year to $14 ...Nov 13, 2023 · FS KKR Capital Corp (NYSE:FSK) is the 2 nd largest holding within BIZD with a portfolio weight of 12.95%, and it’s still one of the most undervalued BDCs I follow.

Market Data is delayed by 15 minutes and is for informational GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that the National Medical Products Administration (NMPA) has approved Shingrix for the prevention of shingles (herpes zoster) in adults aged 50 years or older. Shingrix is a recombinant subunit adjuvanted vaccine given intramuscularly in two doses. Jan 5, 2023 · Given these dynamics, long-term FSK's debt-to-equity ratio is currently 1.19x and Tenet Healthcare (THC) Tenet Healthcare (NYSE: THC ), one of the largest U.S. hospital networks, stands well-positioned to benefit from the aging of America. The company’s Q3 results indicate ... The BDCs managed by FS/KKR are FS KKR Capital C Dec 1, 2023 · FS KKR Capital (NYSE:FSK) pays an annual dividend of $2.56 per share and currently has a dividend yield of 12.86%. FSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 106.22%. Payout ratios above 75% are not desirable because they may not be sustainable. Overview News FS KKR Capital Corp. No significaPHILADELPHIA and NEW YORK, Aug. 9, 2021 /PRNewswire/Overview News FS KKR Capital Corp. No significant news for in t Investors Research Corp boosted its stake in shares of GSK plc (NYSE:GSK – Free Report) by 56.0% during the second quarter, according to the company in its most recent disclosure with the ...The most recent change in the company's dividend was an increase of $0.06 on Monday, November 6, 2023. What is FS KKR Capital's dividend payout ratio? The dividend payout ratio for FSK is: 106.22% based on the trailing year of earnings. 82.05% based on this year's estimates. Real time Fs Kkr Capital (FSK) stock price quote, stock graph, new NYSE - Nasdaq Real Time Price. Currency in USD. Follow. 2W 10W 9M. 19.90 +0.14 (+0.68%) As of 03:32PM EST. Market open. Dividend. FSK announced a cash dividend of 0.05 with an ex-date of Dec....FS KKR Capital Corp. Announces Second Quarter 2023 Results. FSK | August 7, 2023. Declares Third Quarter 2023 Distribution of $0.70 per share, Which When Combined with the Company's Previously Declared $0.05 per share Special Distribution, Results in a Total Third Quarter Distribution of $0.75 per share. Truist Financial Remains a Hold on FS KKR Capital (FSK) November 8, 2[Emma Walmsley, the Chief Executive Officer of GSK plc (NYSECAH. Cardinal Health, Inc. 106.27. +0.39. +0.37%. In this articl Nov 13, 2023 · FS KKR Capital Corp (NYSE:FSK) is the 2 nd largest holding within BIZD with a portfolio weight of 12.95%, and it’s still one of the most undervalued BDCs I follow. FSK's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing. Home Guide ... FSK: NYSE (Stock) FS KKR Capital Corp Payout Change Special Price as of: NOV 27, 11:00 AM EST $19.9 -0.01 0% Dividend (Fwd) $2.56 Yield (Fwd)